Referencias BariForte

1.    Ciudin A, Simó-Servat A, Palmas F, Barahona MJ. Sarcopenic obesity: a new challenge in clinical practice. Endocrinol Diabetes Nutr. 2020;67(10):672-681.
2.    Ballesteros Pomar MD, Vilarrasa García N, Rubio Herrera MÁ, Barahona MJ, Bueno M, Caixás A, et al. Abordaje clínico integral SEEN de la obesidad en la edad adulta. Endocrinol Diabetes Nutr. 2021;68(2):130-136.
3.    Wirunsawanya K, Upala S, Jaruvongvanich V, Sanguankeo A. Whey protein supplementation improves body composition and cardiovascular risk factors in overweight and obese patients: a systematic review and meta-analysis. J Am Coll Nutr.         2018;37(1):60-70.
4.    Dolan E, Artioli GG, Pereira RMR, Gualano B. Muscular atrophy and sarcopenia in the elderly: is there a role for creatine supplementation? Biomolecules. 2019;9(11):642.
5.    Salama A, Abdulla S, Kaminskaya A, et al. Synergistic role of creatine monohydrate in mitigating skeletal muscle wasting and strength decline during GLP-1 receptor agonist therapy: a comprehensive review. Qual Sport. 2026. 
6.    Šantić R, Martinović L, Pavlović N, et al. Lean mass and musculoskeletal preservation in GLP-1-based obesity treatment: nutrition, exercise, supplementation, and monitoring strategies. Metabolites. 2026;16. 
7.    Leite Faria S, et al. Dietary protein intake in bariatric surgery patients: review. Obes Surg. 2011;21:1798-1805.
8.    MC, et al. Protein leucine content and muscle protein synthesis in older women. Am J Clin Nutr. 2018;107(2):217-226.
9.    Layman DK. Protein quantity and distribution: impact on body composition. Front Nutr. 2024;11:1388986.
10.    Majeed M, et al. Evaluation of the Safety and Efficacy of a Multienzyme Complex in Patients with Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study. J Med Food. 2018 Nov;21(11):1120-1128. 
11.    Majeed M, et al. Multi−Enzyme Complex for the Management of Delayed Onset Muscle Soreness after Eccentric Exercise: A Randomized, Double Blind, Placebo Controlled Study. Sports Nutr Ther. 2016, 1:3.